Outset Medical, Inc.
Outset Medical, Inc., a pioneering force in the healthcare technology sector, is headquartered in the United States. Founded in 2010, the company has rapidly established itself as a leader in the development of innovative dialysis solutions, particularly with its flagship product, the Tablo® System. This unique device simplifies the dialysis process, making it more accessible and efficient for patients and healthcare providers alike. With a focus on transforming the dialysis experience, Outset Medical operates primarily in the renal care industry, serving hospitals and clinics across major operational regions in the US. The company has achieved significant milestones, including FDA clearance for its products, positioning itself as a key player in the market. Outset Medical's commitment to enhancing patient care through advanced technology underscores its reputation as a trusted name in the field of medical devices.
DitchCarbon Score
How does Outset Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Outset Medical, Inc.'s score of 25 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Outset Medical, Inc.'s reported carbon emissions
Outset Medical, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing emissions. As the company operates in the medical technology sector, it is essential for them to consider industry standards and best practices in climate action to enhance sustainability and reduce environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Outset Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
